Beacon Health Selects R1 RCM for Expanded Revenue Cycle Services
Apr 23, 2018 12:01 pm UTC| Business
CHICAGO, April 23, 2018 -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced that Beacon Health based in South Bend,...
Brad Kreger Joins Fluidigm as Senior Vice President, Global Operations
Apr 23, 2018 12:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., April 23, 2018 -- Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of Brad Kreger as Senior Vice President, Global Operations. In this role, Kreger leads global...
Apr 23, 2018 12:00 pm UTC| Business
TORONTO, April 23, 2018 -- Gratomic Inc. (“GRAT” or the “Company”) (TSX-V:GRAT) (FRANKFURT:CB81) (WKN:A2JAP3). Gratomic Inc., is pleased to announce that the Company has signed a letter of collaboration (“Agreement”)...
Cypress Commences Trading on the OTCQB Marketplace
Apr 23, 2018 12:00 pm UTC| Business
VANCOUVER, British Columbia, April 23, 2018 -- Cypress Development Corp. (TSX-V:CYP) (OTCQB:CYDVF) (Frankfurt:C1Z1) (“Cypress” or the “Company”) is pleased to announce that the Company has commenced trading on the OTCQB...
Pacific Mercantile Bancorp Reports First Quarter 2018 Operating Results
Apr 23, 2018 12:00 pm UTC| Business
First Quarter Summary Net income of $3.7 million, or $0.16 per shareNo provision for loan and lease losses during the three months ended March 31, 2018Total new loan commitments of $29.2 million and loan fundings of...
Papa Murphy’s Holdings, Inc. to Announce First Quarter 2018 Results on May 9, 2018
Apr 23, 2018 12:00 pm UTC| Business
VANCOUVER, Wash., April 23, 2018 -- Papa Murphy’s Holdings, Inc. (“Papa Murphy’s”) (NASDAQ:FRSH) today announced that it will host a conference call to discuss its first quarter 2018 financial results on Wednesday, May...
Apr 23, 2018 12:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., April 23, 2018 -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today...